Bydureon and Eye pain - a phase IV clinical study of FDA data

Summary:

Eye pain is reported as a side effect among people who take Bydureon (exenatide synthetic), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Metformin, and have Sleep disorder.

The phase IV clinical study analyzes which people have Eye pain when taking Bydureon. It is created by eHealthMe based on reports of 24,229 people who have side effects when taking Bydureon from the FDA, and is updated regularly.

What is Bydureon?

Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 24,309 Bydureon users. Check the latest studies of Bydureon.

What is Eye pain?

Eye pain is found to be associated with 1,746 drugs and 2,474 conditions by eHealthMe. Check the latest studies of Eye pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

24,229 people reported to have side effects when taking Bydureon.
Among them, 15 people (0.06%) have Eye pain.

Among these 15 people:

How long have people been on Bydureon when they have Eye pain? *

What is the gender of people who have Eye pain when taking Bydureon? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Eye pain when taking Bydureon? *

What are other drugs people take besides Bydureon? *

What are other side effects people have besides Eye pain? *

Nausea (feeling of having an urge to vomit): 5 people, 33.33%
Headache (pain in head): 5 people, 33.33%
Blood Glucose Increased: 5 people, 33.33%
Diarrhea: 5 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 26.67%
Weight Decreased: 4 people, 26.67%
Indigestion: 3 people, 20.00%
Tension Headache: 3 people, 20.00%
Abdominal Pain Upper: 3 people, 20.00%
Injection Site Mass: 3 people, 20.00%

What are the existing conditions these people have? *

Indigestion: 2 people, 13.33%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 13.33%
Pain: 2 people, 13.33%
Fungal Infection: 2 people, 13.33%
Oral Herpes (viral infection of mouth): 2 people, 13.33%
Neuropathy Peripheral (surface nerve damage): 2 people, 13.33%
Neuralgia (pain in one or more nerves): 2 people, 13.33%
Nerve Injury: 2 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
Sleep Disorder: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bydureon and have Eye pain?

- Check whether Eye pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bydureon:

Bydureon (24,309 reports)

Eye pain treatments and more:

Eye pain (57,871 reports)

Browse all side effects of Bydureon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye pain:

Eye pain (1,746 drugs)

Browse all the conditions that are associated with Eye pain:

Eye pain (2,474 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on exenatide synthetic (the active ingredients of Bydureon) and Bydureon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.